Delivery Order SPE2DB22D1106-SPE2DB25FESM9
Award Date
6/9/25
Potential Completion Date
6/10/25
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of NALOXONE HCL 4 MG NASAL SPRAY 2S, with a ceiling value of $2,104.88. The contract has a firm fixed-price pricing type and an ultimate completion date of June 6, 2025. The contract is not set aside for a specific business type. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,823.61 firm fixed-price delivery order is for the supply of 4,568,186,025 units of NALOXONE HCL 4 MG NASAL SPRAY 2S, with a completion date of May 9, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Naloxone HCL 4 mg nasal spray. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,197.16 and an ultimate completion date of January 16, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NALOXONE HCL 4 MG NASAL SPRAY 2S, with a ceiling value of $1,315.16 and a completion date of November 13, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,289.81 firm fixed-price delivery order is for 4,567,538,673 units of NALOXONE HCL 4 MG NASAL SPRAY 2S, with a performance period ending on March 12, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,396.62 firm-fixed-price delivery order is for the supply of NALOXONE HCL 4 MG NASAL SPRAY 2S, with a completion date of June 6, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which enables...
This federal contract award is for the delivery of NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,217.40 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a period of performance running through February 2025. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves...
This federal contract award is for the delivery of NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $4,314.26 and an ultimate completion date of April 2, 2025. It was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 1, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,252.28, is for the delivery of NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdose. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 24, 2025. The contract was not set aside for any specific...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4 mg naloxone hydrochloride nasal spray. The contract has a ceiling value of $8,151 and is a firm fixed price delivery order with a completion date of March 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...